Publication Cover
Natural Product Research
Formerly Natural Product Letters
Volume 28, 2014 - Issue 24
718
Views
17
CrossRef citations to date
0
Altmetric
Articles

Extraction optimisation and isolation of triterpenoids from Ganoderma lucidum and their effect on human carcinoma cell growth

, , &
Pages 2264-2272 | Received 08 May 2014, Accepted 22 Jun 2014, Published online: 17 Jul 2014
 

Abstract

The response surface methodology was used to optimise the extraction conditions of Ganoderma lucidum based on a Box–Behnken design. A quadratic model sufficiently simulated the response of ganoderic acid H with a determination coefficient (R2) of 0.98. The optimal condition for extracting triterpenoids was determined to be 100.00% ethanol at 60.22°C for 6.00 h, under which the yield of the reference triterpenoid ganoderic acid H increased from 0.88 to 2.09 mg/g powder. Following extraction, triterpenoid-enriched fraction was further isolated into 23 fractions, and 7 fractions were identified as ganoderic acids A, B, D, G, H and I and ganoderenic acid D. Of the seven triterpenoids, ganoderenic acid D was most cytotoxic with IC50 values of 0.14 ± 0.01, 0.18 ± 0.02 and 0.26 ± 0.03 mg/mL in Hep G2, Hela and Caco-2 cells, respectively. While ganoderic acids A, G and H were relatively non-cytotoxic. The variation of inhibitory effects for these triterpenoids was likely related to their chemical structures.

Additional information

Funding

This work was supported by the Singapore Ministry of Education and National University of Singapore (NUS) [grant number R143-000-143-112].

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.